Dysfunctions of Cellular Oxidative Metabolism in Patients with Mutations in the NDUFS1 and NDUFS4 Genes of Complex I

Arcangela Iuso, Salvatore Scacco, Cláudia Piccoli, Francesco Bellomo, Vittoria Petruzzella, R Trentadue, Michele Minuto, Maria Ripoli, Nazzareno Capitanio, Massimo Zeviani,

Journal of Biological Chemistry · 2006 · 145 citations · 34 references

DOIFull text

Open access

Concepts

Abstract

The pathogenic mechanism of a G44A nonsense mutation in the NDUFS4 gene and a C1564A mutation in the NDUFS1 gene of respiratory chain complex I was investigated in fibroblasts from human patients. As previously observed the NDUFS4 mutation prevented complete assembly of the complex and caused full suppression of the activity. The mutation (Q522K replacement) in NDUFS1 gene, coding for the 75-kDa Fe-S subunit of the complex, was associated with (a) reduced level of the mature complex, (b) marked, albeit not complete, inhibition of the activity, (c) accumulation of H2O2 and O2˙- in mitochondria, (d) decreased cellular content of glutathione, (e) enhanced expression and activity of glutathione peroxidase, and (f) decrease of the mitochondrial potential and enhanced mitochondrial susceptibility to reactive oxygen species (ROS) damage. No ROS increase was observed in the NDUFS4 mutation. Exposure of the NDUFS1 mutant fibroblasts to dibutyryl-cAMP stimulated the residual NADH-ubiquinone oxidoreductase activity, induced disappearance of ROS, and restored the mitochondrial potential. These are relevant observations for a possible therapeutical strategy in NDUFS1 mutant patients. The pathogenic mechanism of a G44A nonsense mutation in the NDUFS4 gene and a C1564A mutation in the NDUFS1 gene of respiratory chain complex I was investigated in fibroblasts from human patients. As previously observed the NDUFS4 mutation prevented complete assembly of the complex and caused full suppression of the activity. The mutation (Q522K replacement) in NDUFS1 gene, coding for the 75-kDa Fe-S subunit of the complex, was associated with (a) reduced level of the mature complex, (b) marked, albeit not complete, inhibition of the activity, (c) accumulation of H2O2 and O2˙- in mitochondria, (d) decreased cellular content of glutathione, (e) enhanced expression and activity of glutathione peroxidase, and (f) decrease of the mitochondrial potential and enhanced mitochondrial susceptibility to reactive oxygen species (ROS) damage. No ROS increase was observed in the NDUFS4 mutation. Exposure of the NDUFS1 mutant fibroblasts to dibutyryl-cAMP stimulated the residual NADH-ubiquinone oxidoreductase activity, induced disappearance of ROS, and restored the mitochondrial potential. These are relevant observations for a possible therapeutical strategy in NDUFS1 mutant patients. Deficiency of complex I (NADH ubiquinone oxidoreductase, EC 1.6.5.3) of the respiratory chain is a major cause of inborn mitochondrial disease (1Robinson B.H. Biochim. Biophys. Acta. 1998; 1364: 271-286Crossref PubMed Scopus (197) Google Scholar, 2Kirby D.M. Crawford M. Cleary M.A. Dahl H.H. Dennett X. Thorburn D.R. Neurology. 1999; 52: 1255-1264Crossref PubMed Google Scholar, 3Loeffen J. Elpeleg O. Smeitink J. Smeets R. Stockler-Ipsiroglu S. Mandel H. Sengers R. Trijbels F. van den Heuvel L. Ann. Neurol. 2001; 49: 195-201Crossref PubMed Scopus (163) Google Scholar, 4Petruzzella V. Papa S. Gene. 2002; 286: 149-154Crossref PubMed Scopus (51) Google Scholar, 5Benit P. Steffann J. Lebon S. Chretien D. Kadhom N. de Lonlay P. Goldenberg A. Dumez Y. Dommergues M. Rustin P. Munnich A. Rotig A. Hum. Genet. 2003; 112: 563-566Crossref PubMed Scopus (49) Google Scholar, 6Bugiani M. Invernizzi F. Alberio S. Briem E. Lamantea E. Carrara F. Moroni I. Farina L. Spada M. Donati M.A. Uziel G. Zeviani M. Biochim. Biophys. Acta. 2004; 1659: 136-147Crossref PubMed Scopus (226) Google Scholar). Leigh syndrome (early onset fatal neurodegenerative disorder) and Leigh syndrome-like disease are the most common clinical phenotypes associated with complex I deficiency. Impairment of complex I has also been reported in Parkinson (7Schapira A.H. Cooper J.M. Dexter D. Clark J.B. Jenner P. Marsden C.D. J. Neurochem. 1990; 54: 823-827Crossref PubMed Scopus (1681) Google Scholar), Alzheimer (8Kim S.H. Vlkolinsky R. Cairns N. Fountoulakis M. Lubec G. Life Sci. 2001; 68: 2741-2750Crossref PubMed Scopus (128) Google Scholar, 9Coskun P.E. Beal M.F. Wallace D.C. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 10726-10731Crossref PubMed Scopus (456) Google Scholar), and Huntington (10Arenas J. Campos Y. Ribacoba R. Martin M.A. Rubio J.C. Ablanedo P. Cabello A. Ann. Neurol. 1998; 43: 397-400Crossref PubMed Scopus (146) Google Scholar) diseases. Complex I is the largest of the respiratory chain enzymes, being composed of seven mitochondrial DNA and at least 39 nuclear DNA-encoded subunits (11Carroll J. Fearnley I.M. Shannon R.J. Hirst J. Walker J.E. Mol. Cell. Proteomics. 2003; 2: 117-126Abstract Full Text Full Text PDF PubMed Scopus (326) Google Scholar). Mutations in structural subunits have been found in ∼40% of the patients with inborn deficiency of complex I. Reported mutations include all of the mitochondrial DNA-encoded subunits (12McFarland R. Schaefer A.M. Gardner J.L. Lynn S. Hayes C.M. Barron M.J. Walker M. Chinnery P.F. Taylor R.W. Turnbull D.M. Ann. Neurol. 2004; 55: 478-484Crossref PubMed Scopus (56) Google Scholar) and twelve nuclear-encoded subunits (3Loeffen J. Elpeleg O. Smeitink J. Smeets R. Stockler-Ipsiroglu S. Mandel H. Sengers R. Trijbels F. van den Heuvel L. Ann. Neurol. 2001; 49: 195-201Crossref PubMed Scopus (163) Google Scholar, 6Bugiani M. Invernizzi F. Alberio S. Briem E. Lamantea E. Carrara F. Moroni I. Farina L. Spada M. Donati M.A. Uziel G. Zeviani M. Biochim. Biophys. Acta. 2004; 1659: 136-147Crossref PubMed Scopus (226) Google Scholar, 13Petruzzella V. Vergari R. Puzziferri I. Boffoli D. Lamantea E. Zeviani M. Papa S. Hum. Mol. Genet. 2001; 10: 529-535Crossref PubMed Scopus (119) Google Scholar, 14Benit P. Slama A. Cartault F. Giurgea I. Chretien D. Lebon S. Marsac C. Munnich A. Rotig A. Rustin P. J. Med. Genet. 2004; 41: 14-17Crossref PubMed Scopus (154) Google Scholar, 15Kirby D.M. Salemi R. Sugiana C. Ohtake A. Parry L. Bell K.M. Kirk E.P. Boneh A. Taylor R.W. Dahl H.H. Ryan M.T. Thorburn D.R. J. Clin. Investig. 2004; 114: 837-845Crossref PubMed Scopus (160) Google Scholar). The nuclear NDUFS4 gene codes for an 18-kDa subunit of the complex (11Carroll J. Fearnley I.M. Shannon R.J. Hirst J. Walker J.E. Mol. Cell. Proteomics. 2003; 2: 117-126Abstract Full Text Full Text PDF PubMed Scopus (326) Google Scholar), which in high eukaryotes contains potential phosphorylation sites for cAMP-dependent protein kinase in both the presequence and the carboxyl-terminal region (EMBL Data Bank). In mammalian (16Scacco S. Vergari R. Scarpulla R.C. Technikova-Dobrova Z. Sardanelli A. Lambo R. Lorusso V. Papa S. J. Biol. Chem. 2000; 275: 17578-17582Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar, 17Technikova-Dobrova Z. Sardanelli A.M. Speranza F. Scacco S. Signorile A. Lorusso V. Papa S. Biochemistry. 2001; 40: 13941-13947Crossref PubMed Scopus (87) Google Scholar, 18Pasdois P. Deveaud C. Voisin P. Bouchaud V. Rigoulet M. Beauvoit B. J. Bioenerg. Biomembr. 2003; 35: 439-450Crossref PubMed Scopus (40) Google Scholar) and human (19Papa S. Scacco S. Sardanelli A.M. Vergari R. Papa F. Budde S. van den Heuvel L. Smeitink J. FEBS Lett. 2001; 489: 259-262Crossref PubMed Scopus (78) Google Scholar) cell cultures cAMP promotes the phosphorylation of the NDUFS4 protein and enhances the functional capacity of complex I. Three recessive mutations in the nuclear NDUFS4 gene have been identified in three unrelated children affected by Leigh syndrome-like syndrome with deficiency of complex I, including an AAGTC duplication at position 466-470 in exon 5 (20van den Heuvel L. Ruitenbeek W. Smeets R. Gelman-Kohan Z. Elpeleg O. Loeffen J. Trijbels F. Mariman E. de Bruijn D. Smeitink J. Am. J. Hum. Genet. 1998; 62: 262-268Abstract Full Text Full Text PDF PubMed Scopus (244) Google Scholar), a single base deletion at position 289/290 in exon 3 (21Budde S.M. van den Heuvel L.P. Janssen A.J. Smeets R.J. Buskens C.A. DeMeirleir L. Van Coster R. Baethmann M. Voit T. Trijbels J.M. Smeitink J.A. Biochem. Biophys. Res. Commun. 2000; 275: 63-68Crossref PubMed Scopus (165) Google Scholar), and a G44A nonsense mutation in the first exon of the gene, introducing a premature termination codon in the sequence coding for the mitochondrial leader peptide (13Petruzzella V. Vergari R. Puzziferri I. Boffoli D. Lamantea E. Zeviani M. Papa S. Hum. Mol. Genet. 2001; 10: 529-535Crossref PubMed Scopus (119) Google Scholar). All three mutations resulted in the disappearance of the 18-kDa subunit and defect in both the activity and assembly of the complex (22Scacco S. Petruzzella V. Budde S. Vergari R. Tamborra R. Panelli D. van den Heuvel L.P. Smeitink J.A. Papa S. J. Biol. Chem. 2003; 278: 44161-44167Abstract Full Text Full Text PDF PubMed Scopus (110) Google Scholar). In the 289/290 deletion in exon 3, which predicts the synthesis of an aberrant and prematurely truncated protein, we found almost complete absence of the NDUFS4 transcript (22Scacco S. Petruzzella V. Budde S. Vergari R. Tamborra R. Panelli D. van den Heuvel L.P. Smeitink J.A. Papa S. J. Biol. Chem. 2003; 278: 44161-44167Abstract Full Text Full Text PDF PubMed Scopus (110) Google Scholar), apparently degraded by Nonsense Mediated Decay (23Hentze M.W. Kulozik A.E. Cell. 1999; 96: 307-310Abstract Full Text Full Text PDF PubMed Scopus (709) Google Scholar). The G44A nonsense mutation in the first exon resulted in stabilization of three alternatively spliced transcript variants of the NDUFS4 gene (24Petruzzella V. Panelli D. Torraco A. Stella A. Papa S. FEBS Lett. 2005; 579: 3770-3776Crossref PubMed Scopus (17) Google Scholar). Recently, large-scale deletion and point mutations in the NDUFS1 gene coding for the 75-kDa Fe-S subunit of complex I have been found (6Bugiani M. Invernizzi F. Alberio S. Briem E. Lamantea E. Carrara F. Moroni I. Farina L. Spada M. Donati M.A. Uziel G. Zeviani M. Biochim. Biophys. Acta. 2004; 1659: 136-147Crossref PubMed Scopus (226) Google Scholar, 25Benit P. Chretien D. Kadhom N. de Lonlay-Debeney P. Cormier-Daire V. Cabral A. Peudenier S. Rustin P. Munnich A. Rotig A. Am. J. Hum. Genet. 2001; 68: 1344-1352Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar) in children with mitochondrial encephalopathy. In this report a detailed study is presented on the functional consequences of the G44A mutation in NDUFS4 and of a C1564A mutation in the NDUFS1 gene (Q522K replacement) (6Bugiani M. Invernizzi F. Alberio S. Briem E. Lamantea E. Carrara F. Moroni I. Farina L. Spada M. Donati M.A. Uziel G. Zeviani M. Biochim. Biophys. Acta. 2004; 1659: 136-147Crossref PubMed Scopus (226) Google Scholar). The assembly and catalytic activity of complex I, mitochondrial energy-transfer, and oxygen-free radical balance were investigated in primary fibroblast cultures of two patients. Reagents and Cell Lines—DMEM, 2The abbreviations used are: DMEM, Dulbecco's modified Eagle's medium; DCF-DA, dichlorofluorescein-diacetate; SOD, superoxide dismutase; PBS, phosphate-buffered saline; LSCM, laser scanning confocal microscopy; ROS, reactive oxygen species. PBS, trypsin (0.05%), EDTA (0.02%), penicillin, streptomycin, calf serum, and fetal bovine serum were from EuroClone. Cholera toxin, dibutyryl cyclic AMP, diphenylene iodonium, glutathione reductase, reduced glutathione, and rotenone were from Sigma. NADH was from Boehringer, decylubiquinone and 3-isobutyl-1-methylxanthine (IBMX) from Calbiochem, and 2′,7′-dichlorofluorescein diacetate, MitoCapture, from Biovision. Mito Tracker Red and MitoSOX was from Molecular Probes; TRIzol, SuperScript reverse transcriptase, and primers from Invitrogen; ATP assay from Promega, and neonatal human dermal fibroblasts (NHDF-neo CC-2509) from Cambrex. Case Report—The patient with the homozygous G44A nonsense mutation in the NDUFS4 gene was a baby diagnosed as a case of Leigh syndrome. The patient with severe lactic acidosis died at the age of 7 months. The homozygous C1564A mutation in the NDUFS1 gene was found in two brothers diagnosed for leukodystrophy; at six months a lactic acidosis appeared in both children, who had a progressive disease course. Cell Culture and Mitoplast Preparation—Control fibroblasts (neonatal human dermal fibroblasts-neo) and patient's fibroblasts were grown in DMEM supplemented with 10% fetal bovine serum, 2 mm glutamine, 100 IU/ml of penicillin, and 100 IU/ml of streptomycin. The growth of the fibroblasts from the NDUFS4 mutant was depressed (doubling time >72 h) as compared with the fibroblasts from the NDUFS1 mutant, whose growth was comparable with that of controls (doubling time ∼24 h). For mitoplast preparation fibroblasts were harvested with 0.05% trypsin and 0.02% EDTA and washed in phosphate-buffered saline, pH 7.4, with 5% calf serum. Cells in PBS were exposed 10 min on ice to 0.2 mg of digitonin/mg cellular protein. Mitoplasts were pelleted at 14,000 × g and resuspended in PBS. Rotenone Titration of Cellular Respiration—Respiration was monitored by oxygen polarography. Enzymatic Spectrophotometric Assay—NADH-UQ oxidoreductase activity: mitoplasts were exposed to ultrasound energy for 15 s at 0 °C, and Vmax and Km were determined as in Ref. 22Scacco S. Petruzzella V. Budde S. Vergari R. Tamborra R. Panelli D. van den Heuvel L.P. Smeitink J.A. Papa S. J. Biol. Chem. 2003; 278: 44161-44167Abstract Full Text Full Text PDF PubMed Scopus (110) Google Scholar. NADH ferricyanide oxidoreductase activity: mitoplasts were added to 700 μl of 50 mm potassium phosphate buffer, MgCl2 5 mm, pH 7.4, in the presence of 1 μg/ml of Antimycin A and 3 mm KCN, and the reduction of 250 μm ferricyanide was measured spectrophotometrically (26Hatefi Y. Methods Enzymol. 1978; 53: 11-14Crossref PubMed Scopus (187) Google Scholar). Cytochrome c oxidase activity was determined on mitoplasts in 700 μl of 10 mm phosphate buffer, pH 7.4, following the oxidation of 10 μm ferrocytochrome c (27Cooperstein S.J. Lazarow A. J. Biol. Chem. 1951; 189: 665-670Abstract Full Text PDF PubMed Google Scholar). Glutathione peroxidase activity was determined as described in Ref. 28Flohe L. Gunzler W.A. Methods Enzymol. 1984; 105: 114-121Crossref PubMed Scopus (4109) Google Scholar. Cells were suspended in PBS and disrupted by exposure to ultrasound. Electrophoretic Procedures and Antibodies—Two-dimensional gel analysis (blue native PAGE/SDS-PAGE) of the mitoplasts and immunoblotting were carried out as in Ref. 22Scacco S. Petruzzella V. Budde S. Vergari R. Tamborra R. Panelli D. van den Heuvel L.P. Smeitink J.A. Papa S. J. Biol. Chem. 2003; 278: 44161-44167Abstract Full Text Full Text PDF PubMed Scopus (110) Google Scholar. Rabbit antiserum against the of the with of the NDUFS4 protein was by against subunits of complex I the subunit of complex the subunit of complex and the subunit of complex were from Molecular were Cells were min at with μm Mito Tracker Red to mitochondrial potential and 10 μm 3 μm MitoSOX for of H2O2 and were by a a to a laser scanning confocal The of the was first with the laser and with the laser F. R. G. J. PubMed Scopus Google Scholar). The of the Mito Tracker Red was monitored with the laser is by and to the D.M. Biol. Med. 1999; PubMed Scopus Google Scholar). The of was by the with the laser ATP ATP was by Biochem. 2002; PubMed Scopus Google Scholar) and by a of harvested from with were washed in PBS supplemented with 5% serum, suspended in PBS, and protein with glutathione was determined as described in Ref. F. Biochem. PubMed Scopus Google Scholar. For of reduced glutathione, were with 10% and the by high The were a × and with an of mm potassium pH of cellular by was reverse to with primers by SuperScript reverse used were superoxide mitochondrial superoxide glutathione peroxidase, of 5 μl of reverse were by and of Complex assembly of complex I in the mitochondrial was by of complex I subunits on of the mitoplast from the patient's The in 1 that the NDUFS4 G44A which the disappearance of the 18-kDa in the assembly of complex I, subunits of the complex to a complex in a position to a complex of also Ref. 22Scacco S. Petruzzella V. Budde S. Vergari R. Tamborra R. Panelli D. van den Heuvel L.P. Smeitink J.A. Papa S. J. Biol. Chem. 2003; 278: 44161-44167Abstract Full Text Full Text PDF PubMed Scopus (110) Google Scholar). The C1564A mutation in the NDUFS1 gene resulted in decreased of a complex I and the of a of the the 18-kDa NDUFS4 subunit was in the complex in the 1 on the catalytic activity of complex I and c in The NDUFS4 mutation was associated with complete suppression of the NADH-ubiquinone oxidoreductase activity. The NDUFS1 mutation was associated with decrease of the Vmax of this activity and an of The activity of complex I was in both the activity of c oxidase was in the ubiquinone oxidoreductase, NADH ferricyanide oxidoreductase, and c oxidase in mitoplasts from and patient's fibroblasts are as Mitoplasts were exposed to ultrasound energy for 15 s at 0 The activity of complex I was measured 50 of in 700 μl of 50 mm potassium phosphate buffer, MgCl2 5 mm, in the presence of 0.2 mm decylubiquinone and 3 mm KCN, pH 7.4, The was with of NADH The activity was for the in the presence of rotenone the activity were to Vmax and Km of The of oxidoreductase and the oxidation of 10 μm ferrocytochrome c were determined at as described of of of measured analysis of patients not not c in a Titration of the of rotenone on fibroblast in the NDUFS1 mutant a decrease of the functional content of the complex of rotenone inhibition of respiratory decreased from to The NDUFS4 mutation resulted in of the rotenone of the residual and Cellular ATP mitochondrial potential was monitored by on fibroblasts with the The of the is by the potential in the a in the high potential and a in the potential As in 3 the NDUFS1 mutation caused a of the mitochondrial the NDUFS4 mutation had on the potential. Exposure to H2O2 in of L. L. M. L. A. R. T. G. J. Cell Biol. 2003; PubMed Scopus Google Scholar). was by the not by the mutation No decrease in cellular ATP was found for mutation fibroblasts were grown in the presence of 10% fetal bovine serum of serum a content of cellular ATP was found in both mutant in in the NDUFS4 mutant, as compared with Cellular and the NDUFS1 mutant fibroblasts we found high of H2O2 by the of we found in the H2O2 content of the NDUFS4 mutant fibroblasts compared with In the NDUFS1 mutant fibroblasts the with the of the mitochondrial Mito Tracker an The MitoSOX a to oxygen superoxide in the mitochondrial in the NDUFS1 fibroblasts as compared with both and NDUFS4 mutant fibroblasts In with the NDUFS4 which caused a the NDUFS1 mutation not the fibroblast growth cell in NDUFS1 mutant fibroblasts exposed to No was observed in the NDUFS4 mutant fibroblasts analysis that the transcript of both and mitochondrial were the in both NDUFS1 and NDUFS4 mutant fibroblasts increase in both transcript and activity of glutathione peroxidase was in the NDUFS1 mutant fibroblasts In the the content of glutathione was the reduced No were observed in the NDUFS4 mutant fibroblasts of on of NDUFS1 of the NDUFS1 mutant fibroblasts to dibutyryl-cAMP resulted in of the residual NADH-ubiquinone oxidoreductase activity of complex I and restored the mitochondrial the H2O2 The homozygous NDUFS1 and NDUFS4 mutations are associated with of These the clinical in the two patients and therapeutical The G44A nonsense NDUFS4 mutation was associated with onset and severe disease course. to mutations of this gene (22Scacco S. Petruzzella V. Budde S. Vergari R. Tamborra R. Panelli D. van den Heuvel L.P. Smeitink J.A. Papa S. J. Biol. Chem. 2003; 278: 44161-44167Abstract Full Text Full Text PDF PubMed Scopus (110) Google Scholar), the mutation caused the disappearance of the protein the assembly of complex I, the complete of the NADH-ubiquinone oxidoreductase activity of the complex, and the of both and cell The C1564A NDUFS1 which a in the 75-kDa Fe-S protein of complex I, was associated with a progressive disease course. The mutation not the NADH-ubiquinone oxidoreductase caused decrease of fibroblast and not growth the NDUFS1 mutation determined a decrease of the mitochondrial which was not observed in the NDUFS4 mutant In the complete of complex I activity and of to a decrease in the cellular ATP content in cell ATP is in high by both and the mitochondrial oxidation of NADH by the which complex I Y. Y. T. T. N. N. N. S. T. Y. S. H. Y. T. 1999; PubMed Scopus Google Scholar). of ATP the and sites of the respiratory chain to the mitochondrial potential. with this is the that serum growth the cellular ATP content in the NDUFS4 mutant mechanism is to the of the disease in the and the severe lactic acidosis in the of ROS level and glutathione ROS in the NDUFS1 mutant The mutation was associated with a increase in the level of H2O2 mitochondria, accumulation of O2˙- in the mitochondrial expression of glutathione peroxidase, and a decrease in the cellular of glutathione and in reduction No were observed in the fibroblasts from the NDUFS4 These observations the that complex I is the major of O2˙- and ROS in human fibroblasts (1Robinson B.H. Biochim. Biophys. Acta. 1998; 1364: 271-286Crossref PubMed Scopus (197) Google Scholar, E. Biol. Med. 2000; PubMed Scopus Google Scholar, T. 2000; PubMed Scopus Google Scholar). The complete of the NADH-ubiquinone oxidoreductase caused by the deletion of the 18-kDa subunit is to from inhibition of a that is also in the reduction of to O2˙- 2005; PubMed Scopus Google Scholar). which to also by cAMP-dependent phosphorylation of the NDUFS4 18-kDa subunit of complex I (16Scacco S. Vergari R. Scarpulla R.C. Technikova-Dobrova Z. Sardanelli A. Lambo R. Lorusso V. Papa S. J. Biol. Chem. 2000; 275: 17578-17582Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar, S. Scacco S. Sardanelli A.M. Vergari R. Papa F. Budde S. van den Heuvel L. Smeitink J. FEBS Lett. 2001; 489: 259-262Crossref PubMed Scopus (78) Google Scholar). In the case of the NDUFS1 the inhibition of the NADH-ubiquinone oxidoreductase to of the 75-kDa Fe-S protein by this The oxidation by oxygen of the NDUFS1 Fe-S is reduced by mutations are to the ferricyanide from the complex, both were associated with activity. In the NDUFS1 mutant dibutyryl-cAMP stimulated the residual NADH-ubiquinone oxidoreductase activity, determined the disappearance of ROS, and restored the mitochondrial potential. The of complex I assembly in NDUFS4 and NDUFS1 mutant fibroblasts to Ref. H. I. T. J. J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar). The absence of the 18-kDa subunit a in the assembly of a mature functional complex, the of an whose was also Ref. 22Scacco S. Petruzzella V. Budde S. Vergari R. Tamborra R. Panelli D. van den Heuvel L.P. Smeitink J.A. Papa S. J. Biol. Chem. 2003; 278: 44161-44167Abstract Full Text Full Text PDF PubMed Scopus (110) Google Scholar). The in the 75-kDa Fe-S subunit of complex I was associated with reduced level of the complex and the presence of a of to the observed in the NDUFS4 The NDUFS4 18-kDa protein in the residual of the mature complex was in the The mutation of the 75-kDa Fe-S protein have the in the assembly of the complex induced of the complex as a of enhanced ROS Ref. F. Shannon R.J. Hirst J. J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar). In the of a functional NADH-ubiquinone oxidoreductase complex I and the severe acidosis to accumulation of and the fatal of the disease in the NDUFS4 mutant In the NDUFS1 mutant the of the NADH-ubiquinone oxidoreductase activity of complex I the severe clinical course. In this mutation an from the enhanced of ROS, which in in a to of and disease and a therapeutical strategy in patients mutations in NDUFS1 in complex I that in on of ROS and of and of for glutathione

References

34